1-3 of 3
Gabriella Angelini
Close
Sort by
Journal Articles

CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in Preclinical Studies

Jessica Lisle, Sushma Krishnamurthy, Amanda Halfond, Lisa Pechilis, Nate Manalo, Melissa Chng, Brikena Gjeci, Gabriella Angelini, Fulton Norman, Caitlin Lourenco, Hannah Mager, Julia Etchin, Yonina Keschner, Mariana Silva, Bethany Mattson, Laura Barreyro, Christina Guttke, John Lydeard, Julian Scherer, Michelle I Lin, Tirtha Chakraborty
Journal: Blood
Blood (2023) 142 (Supplement 1): 3425.
https://doi.org/10.1182/blood-2023-180216
Published: 2023
Journal Articles

Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment

Juliana Xavier-Ferrucio, Gabriella Angelini, Sushma Krishnamurthy, Nipul Patel, Michael Pettiglio, Timothy Collingsworth, Amanda Halfond, Julia Etchin, Yonina Keschner, Guy Mundelboim, Huan Qiu, Ruijia Wang, Gary Ge, John Lydeard, Michelle I Lin, Tirtha Chakraborty
Journal: Blood
Blood (2022) 140 (Supplement 1): 10217–10218.
https://doi.org/10.1182/blood-2022-167513
Published: 2022
Journal Articles

Knock out of CD123 or CLL-1 By CRISPR-Cas9 Editing from Human Hematopoietic Stem Cell Transplants Provide New Possibilities for Increasing Therapeutic Index and Safety for AML Treatment

Chong Luo, Gabriella Angelini, Sushma Krishnamurthy, Jessica Lisle, Meltem Isik, Azita Ghdossi, Christopher Cummins, Michael Pettiglio, Dane Hazelbaker, Gary Ge, Patrick Tavares, Mugdha Nikam, Elizabeth Paik, John Lydeard, Michelle Lin, Tirtha Chakraborty
Journal: Blood
Blood (2021) 138 (Supplement 1): 3818.
https://doi.org/10.1182/blood-2021-146235
Published: 2021